NFE2L2 and acute myeloid leukemia: These results align with prior evidence in acute myeloid leukemia, where decitabine and all-trans retinoic acid (ATRA) exhibit cooperative antitumor activity through inhibition Nrf2/NFE2L2 induced antioxidant response leading to accumulation of ROS production and cytotoxicity.